Mirati Therapeutics Prices 3.25M Share Offering at $17.50/Share
October 23, 2013 at 20:17 PM EDT
Mirati Therapeutics (NASDAQ: MRTX) today announced the pricing of an underwritten public offering of 3,250,000 shares of its common stock at a price to the public of $17.50 per share. The gross proceeds from this offering to Mirati are expected to be approximately $56.9 million, before deducting underwriting discounts and